Monitoring democratic institutions through public records

Independent Agency Rules — Week of Feb 17, 2025

Some government agencies (like the FDA or EPA) are supposed to make decisions based on science and law, not politics. Can the President control what rules they write?

ConfirmedConcern

AI content assessment elevated

AI content assessment elevated with high P2 concern rate. Warrants close examination.

During the week of February 17, 2025, several government actions raised questions about who controls the decisions that independent agencies like the EPA and FDA are supposed to make based on science and law.

The most significant action was an executive order titled Commencing the Reduction of the Federal Bureaucracy, which directs federal agencies to shrink their operations to the "minimum presence and function required by law" and tells budget officials to reject funding for certain programs. This might matter because agencies like the EPA and FDA were created by Congress to make rules based on scientific evidence—and directing them to focus only on essential functions could weaken the protections those agencies provide to public health and the environment. It's worth noting that presidents have always had authority to reorganize government, and the administration has stated its goal is to increase accountability and efficiency. Courts may also block provisions that conflict with existing law, and some targeted functions may be genuinely redundant.

At the same time, bills introduced in both the Senate and House would ban the EPA from using its own chemical safety research—called the Integrated Risk Information System—when writing health and environmental rules. This system is how the EPA evaluates whether chemicals are toxic. Restricting its use could be seen as similar to restricting a doctor from using lab results when diagnosing a patient. That said, some lawmakers and industry groups have long criticized this system as slow and inconsistent, and the bills may be part of a broader negotiation strategy to push reforms rather than a definitive policy shift.

A new executive order also created a Make America Healthy Again Commission run by White House staff that would direct health agencies' research priorities. While presidential health initiatives are common, placing political appointees in charge of scientific research agendas at NIH, CDC, and FDA could shift those agencies away from independent expert judgment.

Limitations: This is AI-generated analysis of published government documents and does not represent findings of fact. How these orders are actually implemented—and whether courts intervene—will determine their real-world impact.